High anthracycline cumulative dose without cardiac toxicity: A possible protective role of morphine
- PMID: 29615547
- PMCID: PMC5998842
- DOI: 10.14744/AnatolJCardiol.2018.65481
High anthracycline cumulative dose without cardiac toxicity: A possible protective role of morphine
References
-
- Zamorano JL, Lancellotti P, Rodriguez Muñoz D, Aboyans V, Asteggiano R, Galderisi M, et al. ESC Scientific Document Group. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines:The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC) Eur Heart J. 2016;37:2768–2801. - PubMed
-
- Kelishomi RB, Ejtemaeemehr S, Tavangar SM, Rahimian R, Mobarakeh JI, Dehpour AR. Morphine is protective against doxorubicin-induced cardiotoxicity in rat. Toxicology. 2008;243:96–104. - PubMed
-
- He SF, Jin SY, Wu H, Wang B, Wu YX, Zhang SJ, et al. Morphine preconditioning confers cardioprotection in doxorubicin-induced failing rat hearts via ERK/GSK-3βpathway independent of PI3K/Akt. Toxicol Appl Pharmacol. 2015;288:349–58. - PubMed
-
- Doroshow JH. Effect of anthracycline antibiotics on oxygen radical formation in rat heart. Cancer Res. 1983;43:460–72. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
